Botulinum toxin type a for great auricular neuralgia.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
01 Aug 2023
Historique:
received: 31 03 2023
revised: 14 06 2023
accepted: 20 06 2023
medline: 14 8 2023
pubmed: 24 6 2023
entrez: 23 6 2023
Statut: ppublish

Résumé

great auricular neuralgia is a rare disorder with only 18 cases described in the literature. Since it's a rare disorder, there are no evidence-based therapeutic recommendations but only case reports to guide physicians. We report a case of great auricular neuralgia treated with botulinum toxin type A subcutaneous injection with significant remission of pain. Botulinum toxin type A could be an effective and safe treatment in this setting; however, more studies are needed to confirm our results.

Identifiants

pubmed: 37352981
pii: S0041-0101(23)00190-3
doi: 10.1016/j.toxicon.2023.107204
pii:
doi:

Substances chimiques

Botulinum Toxins, Type A EC 3.4.24.69
Neuromuscular Agents 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

107204

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yan Tereshko (Y)

Clinical Neurology Unit, Department of Neuroscience, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100, Udine, Italy. Electronic address: tereshko.yan@spes.uniud.it.

Christian Lettieri (C)

Neurology Unit, Department of Neuroscience, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100, Udine, Italy.

Enrico Belgrado (E)

Neurology Unit, Department of Neuroscience, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100, Udine, Italy.

Simone Dal Bello (S)

Clinical Neurology Unit, Department of Neuroscience, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100, Udine, Italy.

Gian Luigi Gigli (GL)

Department of Medicine (DAME), University of Udine, Udine, Italy.

Mariarosaria Valente (M)

Clinical Neurology Unit, Department of Neuroscience, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100, Udine, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH